Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis.
Miller RG, Moore DH 2nd, Gelinas DF, Dronsky V, Mendoza M, Barohn RJ, Bryan W, Ravits J, Yuen E, Neville H, Ringel S, Bromberg M, Petajan J, Amato AA, Jackson C, Johnson W, Mandler R, Bosch P, Smith B, Graves M, Ross M, Sorenson EJ, Kelkar P, Parry G, Olney R; Western ALS Study Group.
Miller RG, et al. Among authors: moore dh 2nd.
Neurology. 2001 Apr 10;56(7):843-8. doi: 10.1212/wnl.56.7.843.
Neurology. 2001.
PMID: 11294919
Clinical Trial.